NDC 55513-155 - BLINCYTO
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55513-155
- Package NDCs from labels
- 55513-155-01
- Manufacturer
- Amgen, Inc
- Effective date
- 2026-04-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BLINCYTO - Amgen, Inc | Amgen, Inc | 2026-04-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BLINATUMOMAB | ACTIVE INGREDIENT | 4FR53SIF3A | BLINCYTO (BLINATUMOMAB) KIT [AMGEN INC] | 7 | |
| BLINATUMOMAB | ACTIVE MOIETY | 4FR53SIF3A | BLINCYTO (BLINATUMOMAB) KIT [AMGEN INC] | 7 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | BLINCYTO (BLINATUMOMAB) KIT [AMGEN INC] | 7 | |
| LYSINE HYDROCHLORIDE | INACTIVE INGREDIENT | JNJ23Q2COM | BLINCYTO (BLINATUMOMAB) KIT [AMGEN INC] | 7 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | BLINCYTO (BLINATUMOMAB) KIT [AMGEN INC] | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | BLINCYTO (BLINATUMOMAB) KIT [AMGEN INC] | 7 | |
| TREHALOSE DIHYDRATE | INACTIVE INGREDIENT | 7YIN7J07X4 | BLINCYTO (BLINATUMOMAB) KIT [AMGEN INC] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| F09 LTGO | ADELHEID AQUA, AGRIMONY, MALUS SYLVESTRIS, ARSENICUM ALBUM, FILAREE, HEATHER, HORSE CHESTNUT, LACHESIS MUTUS, NASTURTIUM, RED HORSE CHESTNUT, SEPIA, SILICEA, STRAMONIUM, VERBENA OFFICINALIS | Apex Energetics Inc. | bd1e652f-b3a4-c5bd-e053-2995a90ae03f | 2024-01-08 | Warnings | 059QF0KO0R |
| Fendall 2000 Pure Flow | PURIFIED WATER | Honeywell Safety Products USA, Inc. | b56ef662-fec2-4d94-e053-2995a90aba2b | 2024-01-06 | Warnings | 059QF0KO0R |
| Leader Eye Wash | PURIFIED WATER | Cardinal Health | 8d3ad11f-1945-f838-e053-2995a90a7aa5 | 2023-12-23 | Warnings | 059QF0KO0R |
| Oracit | CITRIC ACID AND SODIUM CITRATE | CMP Pharma, Inc. | bc26abed-8e6e-475d-8ab3-abf7d0377003 | 2023-12-07 | Adverse reactions | 2968PHW8QP |
| Eye Wash | WATER | Jiangxi Zhenmei Biological Technology Co.,Ltd | c68795b8-bf68-0d01-e053-2a95a90abebb | 2023-12-04 | Warnings | 059QF0KO0R |
| Phexxi | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | Evofem, Inc. | 173ff411-7227-47b0-94dc-844e1ebaf14e | 2023-11-21 | Warnings, Adverse reactions | 2968PHW8QP |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | AZELAIC ACID, SALICYLIC ACID | ANUBIS COSMETICS SL | ebf3153d-30f5-54e4-e053-2995a90a74b1 | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | SODIUM BICARBONATE, ALOE BARBADENSIS LEAF JUICE, IMIDAZOLIDINYL UREA | ANUBIS COSMETICS SL | ebf4b3ab-34e1-185a-e053-2a95a90ace3a | 2023-09-05 | Warnings | 059QF0KO0R |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | DMAE | ANUBIS COSMETICS SL | f22b212d-d21d-5984-e053-2995a90a683e | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Vital Line | HYDROLYZED ELASTIN, HYDROLYSED COLLAGEN, COCOGLYCERIDES | ANUBIS COSMETICS SL | ebe024f7-7c45-ad60-e053-2995a90a45d6 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | PROTEOGLYCAN, GLYCERIN, BUTYLENE GLYCOL | ANUBIS COSMETICS SL | ebdddcec-f5da-51fe-e053-2995a90a6167 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.